2000
DOI: 10.1001/archderm.136.7.837
|View full text |Cite
|
Sign up to set email alerts
|

A Case of Angiolymphoid Hyperplasia With Eosinophilia Treated With Intralesional Interferon Alfa-2a

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
21
0

Year Published

2001
2001
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 35 publications
(22 citation statements)
references
References 19 publications
1
21
0
Order By: Relevance
“…Recently, the use of intralesional IFN-·2a has been reported [9]. In our patient, we have successfully used intralesional IFN-·2b with the same results.…”
supporting
confidence: 72%
“…Recently, the use of intralesional IFN-·2a has been reported [9]. In our patient, we have successfully used intralesional IFN-·2b with the same results.…”
supporting
confidence: 72%
“…Although the etiopathogenesis of ALHE is not fully known, it is mainly related to trauma, hyperestrogenemia, infectious agents, environmental factors (insect bite), atopy, disorders in the immunological mechanism [2,3]. In the literature, it has been reported cases associated with hyper estrogenemic conditions (pregnancy, use of oral contraceptives) [4][5][6][7].…”
Section: Discussionmentioning
confidence: 99%
“…Another option is to follow up the lesion 3-6 months for the possibility of spontaneous regression [2]. Surgical excision which has a high success rate is widely used [10,11].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Other therapeutic options less commonly used include isotretinoin, interferon, pentoxifylline, imiquimod, cryotherapy and laser. [33][34][35][36][37][38][39][40] …”
Section: Angiolymphoid Hyperplasia With Eosinophilia (Alhe)mentioning
confidence: 99%